generated cell lines displaying pluripotent stem cell marker expression, a normal karyotype and the capability to differentiate into the three germ layer lineages.
Resource 
Resource utility
Retinitis pigmentosa-11 (RP11) is caused by dominant mutations in the PRPF31 gene, however up to 30% of PRPF31 mutation carriers are non-penetrant. The two iPSC lines described here were derived from an RP11 patient and his unaffected mother and provide a unique opportunity to examine the non-penetrance of RP11 mutations.
Resource details
RP11 is the most common form of autosomal dominant retinitis pigmentosa and is caused by dominant mutations in the PRPF31 gene, which encodes the pre-RNA processing factor-31 protein. Despite the ubiquitous expression of PRPF31, mutations in this gene specifically affect the retina, leading to visual impairment and retinal degeneration. The pathophysiology of RP11 is thought to be driven by PRPF31 haploinsufficiency (Rose and Bhattacharya, 2016) , with retinal tissues preferentially affected due to their high dependence on alternative splicing (Wilkie et al., 2006) . Reduced levels of total PRPF31 transcript as well as a delayed rate of spliceosome assembly and pre-mRNA processing have been reported in RP11 patients (Frio et al., 2008) . Interestingly, RP11 displays non-penetrance in affected families, with 30% of carriers remaining free from retinal disease. The non-penetrance of PRPF31 mutations has been associated with modifying factors influencing expression of the unaffected PRPF31 allele, such as promoter elements and transcriptional repressors (Rose and Bhattacharya, 2016) .
We identified an Indigenous Australian family affected by RP11. Affected individuals displayed posterior subcapsular cataract, rod cone dystrophy and macular cysts with onset of symptoms ranging from 5 to 25 years of age. All affected siblings (n = 4) carried the NM_015629.3:c. 1205C > A p.(Ser402Ter) mutation. Dermal fibroblasts were cultured from skin biopsies taken from an affected RP11 patient and his unaffected mother, both of whom carried the c.1205C > A mutation in PRPF31. The presence of the c.1205C > A mutation in each fibroblast line was confirmed Sanger sequencing of a PCR product (Fig. 1A) . Fibroblasts from each patient were transfected with episomal plasmids containing OCT4, SOX2, KLF4, L-MYC, LIN28, shRNA for p53 and mir302/367 microRNA. After 20-25 days, colonies were picked for clonal expansion. LEIi008-A iPSC were derived from the affected male patient, while LEIi009-A iPSC were derived from his unaffected mother (Table 1, Table 2 ). Both lines displayed morphology typical of pluripotent stem cell cultures (Fig. 1A) . DNA fingerprinting by short tandem repeat analysis demonstrated each iPSC line matched its donor fibroblast line at 16 loci ( Supplementary Fig.  S1 ). Expression of the OCT4, NANOG and SOX2 proteins as well as the pluripotency marker TRA-1-81 was demonstrated in both lines by immunocytochemistry (Fig. 1B) . Digital karyotyping by genome-wide SNP profiling and copy number variation analysis demonstrated LEIi008-A nor LEIi009-A had undergone genomic alterations, with both lines displaying a normal karyotype (46,XY and 46,XX, respectively, Fig. 1C , Supplementary  Fig. S2 ). Quantitative RT-PCR demonstrated both LEIi008-A and LEIi009-A expressed similar levels of pluripotency marker expression to a commercial control human iPSC line (Fig. 1D ). PCR screening demonstrated both lines were negative for mycoplasma and for episomal reprogramming plasmids ( Supplementary Fig. S3 ). After two weeks of spontaneous differentiation, embryoid bodies derived from LEIi008-A and LEIi009-A expressed markers of ectoderm (PAX6, OTX1), mesoderm (DCN, GATA2) and endoderm (AFP) (Fig. 1E) . To demonstrate the capacity for retinal differentiation, LEIi008-A and LEIi009-A were differentiated as retinal organoids. After 2 months, both lines produced retinal organoids containing pigmented RPE cells. RPE cells were isolated from retinal organoid cultures and cultured as pure monolayers (Fig. 1F , micrographs). After 3 weeks of differentiation, quantitative RT-PCR analysis demonstrated iPSC-RPE from both donors expressed the RPE markers RPE65 and BEST1 and downregulated OCT4 expression (Fig. 1F, graph) .
Materials and methods

Cell culture and reprogramming
Patient fibroblasts were cultured in DMEM medium supplemented with 10% fetal calf serum and antibiotic-antimycotic (ThermoFisher). Patient iPSCs were cultured in feeder-free conditions, on Geltrex-coated (ThermoFisher) culture plates in TeSR-E8 medium (StemCell Technologies). For passaging, iPSC were treated with EDTA Buffer (1xDPBS without Ca +2 and Mg +2 /0.5 mM EDTA/30 mM NaCl) for 5 min at room temperature. The buffer was then removed and replaced with TeSR-E8 media. Colonies were then mechanically scraped into the media and seeded into new Geltrex-coated culture wells at a ratio of 1:3-1:5. Media changes were performed daily and passaging was performed every 4-5 days. All cultures were maintained in a humidified incubator at 37°C with 5% CO 2 . Patient fibroblasts were reprogrammed using the Episomal iPSC Reprogramming Plasmid kit (SC900A-1, System Biosciences), according to the manufacturer's instructions. Colonies were picked for clonal expansion on days 21-25. PCR screening for episomal plasmids was performed at passage 9 for LEIi008-A and passage 10 for LEIi009-A, with fibroblasts transfected with reprogramming episomes and early passage iPSC used as positive controls. PCR was performed using SYBR PCR Master Mix (QIAGEN) and 200 nM of each primer. The reactions were performed on the CFX Connect Real-Time PCR Detection System (Biorad) using the following cycling conditions: 95°C for 5 s, then 30 cycles of 95°C for 10s and 60°C for 15 s. Mycoplasma testing was performed using the Lookout Mycoplasma PCR Detection Kit (SigmaAldrich) according to the manufacturer's instructions. A commercial iPSC line (ThermoFisher, Cat#A18945, HuiPSC) was used as a control.
iPSC differentiation
For trilineage differentiation, iPSCs were cultured as embryoid bodies (EBs). IPSC were treated with EDTA Buffer for 5 min at room temperature, the buffer was then removed and replaced with TeSR-E8 media containing 10 μM Y27632 (Abcam). Colonies were mechanically scraped into the media, and then seeded into Greiner suspension culture 6 well plates in TeSR-E8 media supplemented with 10 μM Y27632. On day 3, the media was changed to DMEM/F12 supplemented with 20% knockout serum replacement (KSR), Minimal Essential Media Non-Essential Amino Acids Solution (NEAA) and antibiotic-antimycotic (ThermoFisher). Media was changed every second day. On day 14, EBs were collected for qPCR analysis. Trilineage differentiation was assessed by the induction of genes for ectoderm (PAX6, OTX1) endoderm (AFP) and mesoderm (DCN, GATA2). For directed differentiation into retinal organoids we followed a previously published protocol (Mellough et al., 2012) . After 2 months of differentiation, organoids containing pigmented RPE were collected and treated with TrypLE™ Express Enzyme (ThermoFisher) for 10 min at 37°C. The RPE cells were seeded into Geltrex-coated wells of a 24 well plate in RPE media (DMEM/F12, NEAA, B27, N2, 10 ng/ml IGF-1, 4% KSR and antibiotic-antimycotic).
qPCR analysis
Total mRNA was isolated using TRIzol Reagent (ThermoFisher) and cDNA was synthesized using the RT 2 First Strand Kit (Qiagen). qPCR reactions were prepared using RT 2 SYBR Green qPCR Mastermixes (Qiagen),
(caption on next page)
and performed using the CFX Connect Real-Time System (BioRad). Data was analyzed using the ΔΔCT method. Gene expression values were normalized to GAPDH expression. Primers used are listed in Table 3 .
Immunostaining analysis
Cells were fixed with 4% paraformaldehyde for 15 min at 37°C, washed, then permeabilized using phosphate buffered saline (PBS) with 0.3% Triton X-100 for 15 min. The cells were then incubated in blocking buffer (5% normal goat serum with 0.3% Triton X-100 (Sigma-Aldrich) in PBS) for 1 h at room temperature. Primary antibodies were diluted in blocking buffer and applied at 4°C overnight. Secondary antibodies were applied for 2 h at room temperature. Nuclei were stained with DAPI. Antibodies used are listed in Table 3 . Cells were examined using the Olympus BX60 fluorescence microscope and imaged using Olympus DP-Controller 3.1.1.267 acquisition software (Olympus Corporation, Tokyo, Japan).
Digital karyotyping
Digital karyotyping was performed on LEIi008-A (passage 4) and LEIi009-A (passage 10) iPSC using the Illumina HumanCoreExome-24 Beadchip SNP array (D'Antonio et al., 2017) . DNA was isolated using the FlexiGene DNA kit (QIAGEN). CNV analysis was performed on GenomeStudio 2.0 software using the CNVpartition 2.0 plugin (Illumina). To identify genomic alterations (deletions or duplications over 500 kb), B allele frequencies (Fig. 1C) , LogR ratios and CNV values were Fig. 1 . A: Sanger sequencing of the PRPF31 gene demonstrated the presence of the c.1205C > A mutation in the parental fibroblasts used to generate the LEIi009-A and LEIi009-A iPSC lines (chromatograms). Both LEIi008-A and LEIi009-A displayed morphologies typical of pluripotent stem cell colonies (images). B: The expression of pluripotency markers (OCT4, NANOG, SOX2 and TRA-1-81) in LEIi008-A and LEIi009-A was demonstrated by immunocytochemistry. Nuclei were counterstained with DAPI (merged images). C: Digital karyotyping of LEIi008-A and LEIi009-A was performed using the Illumina HumanCoreExome-24 Beadchip SNP array. B-allele frequencies were plotted against genomic location for 500,000 human SNPs, demonstrating normal, 46,XY and 46,XX karyotypes in each line respectively. D: Quantitative RT-PCR demonstrated similar levels of expression of pluripotency genes (OCT4, NANOG, and KLF4) in LEIi008-A (grey bars) and LEIi009-A (dark grey bars) and a commercial human iPSC line (white bars). Relative expression values were normalised to GAPDH expression using the ΔCt method. Error bars indicate standard deviation. E: Expression of ectodermal (PAX6, OTX1), mesodermal (DCN, GATA2) and endodermal (AFP) genes was increased in embryoid bodies (black bars) derived from LEIi008-A (left graph) and LEIi009-A (right graph), compared with undifferentiated iPSC (grey bars). Relative expression values were normalised to GAPDH expression using the ΔCt method. Error bars indicate standard deviation. F: Monolayers of RPE cells could be derived from LEIi008-A (left image) and LEIi009-A (right image) iPSC. Quantitative PCR analysis demonstrated expression of the RPE markers RPE65 and BEST1 was upregulated in RPE derived from both patient iPSC lines, while expression of OCT4 was downregulated. Expression values were calculated using the ΔΔCt method, normalised to GAPDH and expressed as fold changes compared with undifferentiated iPSC. Error bars indicate standard deviation. Fig. S2 ). This method does not reveal copy number neutral changes such as balanced translocations.
Microsatellite analysis
Analysis of microsatellites was performed using the PowerPlex 16HS system (Promega, performed at the Australian Genome Research Facility). Patient fibroblasts (1093-FB, 1374-FB), LEIi008-A and LEIi009-A were genotyped at the loci D18S51, D21S11, TH01, D3S1358, Penta E, FGA, TPOX, D8S1179, vWA, CSF1PO, D16S539, D7S820, D13S317, D5S818, Penta D and Amelogenin ( Supplementary  Fig. S1 ). Results are shown as a heatmap, demonstrating matching genotypes at all loci examined. 
